NCT06497075View on ClinicalTrials.gov

Co-administration of IVM and ALB in School-based Deworming in Uganda

CompletedOBSERVATIONAL
Enrollment

8,767

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 16, 2024

Study Completion Date

October 19, 2024

Conditions
HelminthiasisIntestinal Worms
Interventions
DRUG

Albendazole 400mg

Single oral dose of Albendazole 400mg tablet

DRUG

Ivermectin 3 MG

Generic ivermectin 3mg tablets given as a single oral dose of 200ug/kg using a dose-pole (height categories: 90-119 cm: 1 tablet , 120-140 cm: 2 tablets, 141-158 cm: 3 tablets or \> 158 cm: 4 tablets)

Trial Locations (2)

Unknown

Makerere University, College of Humanities and Social Sciences, Kampala

Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health, Kampala

All Listed Sponsors
collaborator

Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health, Uganda

UNKNOWN

collaborator

Makerere University

OTHER

lead

Jennifer Keiser

OTHER

NCT06497075 - Co-administration of IVM and ALB in School-based Deworming in Uganda | Biotech Hunter | Biotech Hunter